Lawsuit Filed September 29, 2014 Over Allegations that Eli Lilly Failed to Warn about Risks Associat

Eli Lilly failed to warn that the testosterone replacement drug, Axiron, may increase the risk of heart attack and stroke, a lawsuit filed in federal court alleges. Parker Waichman LLP notes that there have been safety concerns regarding testosterone therapy following reports that they may carry cardiovascular risks. Port Washington, New York (PRWEB) October 09, 2014 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs and medical devices, comments on a lawsuit filed on September 29, 2014 against Eli Lilly over its testosterone r
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories